SCHEMBL7767320

SCHEMBL7767320

C[C](C)Cc1cccc(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.56
DRD2 P14416 2/20 0.52
DRD1 P21728 2/20 0.52
TAAR1 Q96RJ0 1/20 0.52
CHRM2 P08172 2/20 0.52
CHRM1 P11229 2/20 0.52
CHRM3 P20309 2/20 0.52
CYP3A4 P08684 2/20 0.50
CTBP2 P56545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PKM P14618 1/20 0.50
ALOX15 P16050 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
LMNA P02545 2/20 0.48
KMT2A Q03164 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16273850 0.83 ENPP2 (0.52) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL200141 0.83 CTBP2 (0.56) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL29473925 0.77 DRD2 (0.67) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL30427127 0.77 CTBP2 (0.59) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL27842022 0.77 PRKCI (0.47) CYP3A4KMT2A
SCHEMBL22981807 0.77 CTBP2 (0.59) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL216654 0.77 DRD2 (0.67) ENPP2DRD2DRD1TAAR1CHRM2
SCHEMBL6616564 0.77 TP53 (0.44) CYP1A2MAPK1LMNAKMT2AMAPT
SCHEMBL27619612 0.77 CTBP2 (0.53) TAAR1CTBP2ACHE
SCHEMBL17847703 0.76 ENPP2 (0.60) ENPP2DRD2DRD1TAAR1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001091796-A2 METHODS, COMPOUNDS AND COMPOSITIONS FOR TREATING GOUT GUILFORD PHARMACEUTICALS INC. (US) 2001-12-06 WO disclosed
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed